Innovation Performance Group (2019) : Strong -
Total population (2019) 3572583
Population per km² (2017) 170
Proportion population older 65 year % 20,47%
Norte or Northern Portugal is the most populous region in Portugal, ahead of Lisboa, with a population of 3.7 million. Portugal has a vibrant and innovative research and development ecosystem and a high quality health care system.
Under the auspices of the Health Cluster Portugal (HCP), the Portuguese "Health ecosystem" is developing innovative projects in areas which include active and healthy ageing, translational and clinical research, ambient assisted living, eHealth, and health tourism. Particular strategic areas of interest include preventative, personalised and participatory medicine (diseases - neurodegenerative, cancer, cardiovascular, degenerative osteoarticular, inflammatory, infectious, metabolic).
Within Portugal universities, R&D institutions, hospitals and companies are all working in collaboration in the development of new solutions for improving human health.
Is the region looking for international/European/interregional collaboration opportunities?
Yes - H2020 projects, NIH projects.
Member ICPerMed? no
Mountain ? > 50 % of surface in mountain areas
Member Euregha? no
Adriatic-Ionian MacroRegion? no
InnoStars Region? no
Northern Sparsely Populated Area (NSPA)? no
PM region according EC? no
Baltic Sea MacroRegion? no
S3MedTech region? no
Danube MacroRegion? no
S3P4PM region? no
Alpine MacroRegion? no
Regions4PM region? no
S3ClusSport member? no
Central Europe? no
Council of European BioRegions (CEBR)? no
European Regions Research & Innovation Network (ERRIN)? no
Vanguard Initiative? yes
National level: Strategy for Research and Innovation for Smart Specialisation
National level: Basic Law of Health
Topics covered by policies : Population genomics initiative (cfr 1 million genomes participation); Medical research and innovation (-omics, biomarkers, diagnostics, etc.); Education, training and skill development; Prediction and prevention; ICT/genomics, health, lifestyle data(infrastructure)
NACE Personalised Medicine/Personalised Health elated to Research and Innovation objectives:
C.21 - Basic pharmaceutical products and pharmaceutical preparations; C.32 - Other manufacturing; Q.86 - Human health activities; M.72 - Scientific research and development
Scientific domain NABS Personalised Medicine/Personalised Health related to Research and Innovation: NABS07 - Health; NABS133 - R&D related to Medical Sciences - financed from other sources than GUF
Policy objective Personalised Medicine/Personalised Health related related to Research and Innovation objectives: H.51 - New or improved organisational models
Policy document (RIS3): Yes
Policy document PM@RIS3: Yes - Health and Life Sciences: Consolidate links between research and business, especially in the areas of tissue engineering, cancer, neurosciences and surgical procedures
BIOLOGIC@ - Une perspective BioÉconomique du Futur
Digital Innovation Hubs:
iMan Norte Hub - Digital Innovation Hub for Customer-Driven Manufacturing @ Norte
Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?
General perception of the implementation level of PM in the region - Medium
Rate of the need for developing and implementing PM in the region - High
Rate of the need for increasing support/funding for PM activities in the region - High
Rate of the need for increasing the capacity of PM skills in the region - Medium
Rate of the genomics literacy of the citizens in the region - Low
Rate of the need for increasing interregional collaboration in PM - High
CC BY 2.5,